BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16476174)

  • 1. Welfare effects of the use of recombinant bovine somatotropin in the USA.
    Losinger WC
    J Dairy Res; 2006 May; 73(2):134-45. PubMed ID: 16476174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impacts of reduced milk production associated with papillomatous digital dermatitis in dairy cows in the USA.
    Losinger WC
    J Dairy Res; 2006 May; 73(2):244-56. PubMed ID: 16569275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic and environmental feasibility of a perennial cow dairy farm.
    Rotz CA; Zartman DL; Crandall KL
    J Dairy Sci; 2005 Aug; 88(8):3009-19. PubMed ID: 16027215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic evaluation of recombinant bovine somatotropin approval in Japan.
    Kinoshita J; Suzuki N; Kaiser HM
    J Dairy Sci; 2004 May; 87(5):1565-77. PubMed ID: 15291007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of repeated high dose administration of recombinant bovine somatotropin in lactating dairy cows.
    Marcek JM; Seaman WJ; Nappier JL
    Vet Hum Toxicol; 1989 Oct; 31(5):455-60. PubMed ID: 2603366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lactation number, year, and season of initiation of lactation on milk yield of cows hormonally induced into lactation and treated with recombinant bovine somatotropin.
    Mellado M; Antonio-Chirino E; Meza-Herrera C; Veliz FG; Arevalo JR; Mellado J; de Santiago A
    J Dairy Sci; 2011 Sep; 94(9):4524-30. PubMed ID: 21854924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic implications of bovine somatotropin use for the Arizona dairy industry.
    Shoeffling JR; Angus RC; Armstrong DV; Huber JT
    J Dairy Sci; 1991 Jul; 74(7):2347-52. PubMed ID: 1894823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The empirical impact of bovine somatotropin on New York dairy farms.
    Tauer LW; Knoblauch WA
    J Dairy Sci; 1997 Jun; 80(6):1092-7. PubMed ID: 9201578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of retail milk composition as affected by label claims regarding farm-management practices.
    Vicini J; Etherton T; Kris-Etherton P; Ballam J; Denham S; Staub R; Goldstein D; Cady R; McGrath M; Lucy M
    J Am Diet Assoc; 2008 Jul; 108(7):1198-203. PubMed ID: 18589029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economics of using bovine somatotropin in dairy cows and potential impact on the US dairy industry.
    Schmidt GH
    J Dairy Sci; 1989 Mar; 72(3):737-45. PubMed ID: 2715466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant bovine somatotropin for up to two consecutive lactations on dairy production traits.
    McBride BW; Burton JL; Gibson JP; Burton JH; Eggert RG
    J Dairy Sci; 1990 Nov; 73(11):3248-57. PubMed ID: 2273151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of reduced milk production associated with Johne's disease on dairy operations in the USA.
    Losinger WC
    J Dairy Res; 2005 Nov; 72(4):425-32. PubMed ID: 16223457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of misty-fan cooling and supplemental rbST on rumen function and milk production of crossbred Holstein cattle during early, mid and late lactation in a tropical environment.
    Chanchai W; Chanpongsang S; Chaiyabutr N
    Anim Sci J; 2010 Apr; 81(2):230-9. PubMed ID: 20438505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine somatotropin: review of an emerging animal technology.
    Bauman DE
    J Dairy Sci; 1992 Dec; 75(12):3432-51. PubMed ID: 1474210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of dairy cows with recombinant bovine somatotropin: genetic and phenotypic aspects.
    Leitch HW; Burnside EB; McBride BW
    J Dairy Sci; 1990 Jan; 73(1):181-90. PubMed ID: 2312882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the effects of sometribove zinc suspension on the production and health of lactating dairy cows.
    St-Pierre NR; Milliken GA; Bauman DE; Collier RJ; Hogan JS; Shearer JK; Smith KL; Thatcher WW
    J Am Vet Med Assoc; 2014 Sep; 245(5):550-64. PubMed ID: 25148097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health and reproductive performance of dairy cows treated for up to two consecutive lactations with bovine somatotropin.
    Burton JL; McBride BW; Burton JH; Eggert RG
    J Dairy Sci; 1990 Nov; 73(11):3258-65. PubMed ID: 2273152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows.
    Collier RJ; Miller MA; McLaughlin CL; Johnson HD; Baile CA
    Domest Anim Endocrinol; 2008 Jul; 35(1):16-23. PubMed ID: 18325721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bovine somatotropin on the cost of producing milk: Estimates using propensity scores.
    Tauer LW
    J Dairy Sci; 2016 Apr; 99(4):2979-2985. PubMed ID: 26874420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of growth hormone receptor 1A messenger ribonucleic acid in liver of dairy cows during lactation and after administration of recombinant bovine somatotropin.
    Kobayashi Y; Vandehaar MJ; Tucker HA; Sharma BK; Lucy MC
    J Dairy Sci; 1999 Sep; 82(9):1910-6. PubMed ID: 10509249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.